More children died from the flu last season than in any year since the 2009 swine flu pandemic, with many of them being unvaccinated. This has led doctors to explore new methods to boost vaccination rates. One promising option is the FluMist Home, the first at-home nasal flu vaccine.
Approved last fall, FluMist Home is available for children ages 2 and older and adults up to 49. This innovative vaccine aims to help those who fear needles—a common issue, especially among young kids. A study from the University of Michigan found that about 30% of young adults are also afraid of needles.
Dr. Zachary Hoy, a pediatric infectious disease specialist, noted that many children fear vaccinations because they don’t fully understand their importance. He pointed out, “The anxiety before the shot often feels worse than the shot itself.”
How Does FluMist Home Work?
FluMist was first approved in 2003 but faced challenges after the 2009 swine flu pandemic. Researchers found it less effective than other vaccines, leading the CDC to recommend against it in 2016. However, after a reformulation, it returned to the market in 2018 and has since shown effectiveness comparable to injectable vaccines.
According to AstraZeneca spokesperson Andrew Leone, FluMist Home is a safe, needle-free option for flu protection. For the upcoming season, it contains three virus strains: A/H1N1, A/H3N2, and a B strain. Vaccines like FluMist typically have an effectiveness rate between 40% and 60% in preventing severe illness.
Accessibility and Insurance Coverage
FluMist Home is available exclusively online. To order, users must fill out a medical screening questionnaire that will be reviewed by a healthcare professional. A temperature monitor in the delivery package ensures that the vaccine has been kept at the right temperature.
Christina Aungst from GoodRx estimates that those with insurance may only pay around $8.99 for shipping. However, without insurance, FluMist is only available in healthcare settings.
While most insurance plans cover FluMist when administered in a clinic, experts like Dr. Scott Roberts express concern about the proper administration of the vaccine without medical supervision. Factors like a runny nose or incorrect storage at home could complicate its use.
Despite these concerns, Dr. Kristina Bryant emphasizes that all flu vaccines offer similar protection. She believes that making a nasal vaccine available for home administration may help people get vaccinated more easily.
As many healthcare experts and organizations push for higher vaccination rates, the introduction of user-friendly options like FluMist Home reflects a progressive step in public health efforts. Ultimately, increasing vaccination rates is crucial for preventing illnesses and protecting vulnerable populations. For more details about flu vaccine effectiveness, check the CDC’s effectiveness studies.
